Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

SB 269,652

Known as: SB-269,652, SB269,652 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Distinctive binding properties of the negative allosteric modulator, [3H]SB269,652, at recombinant dopamine D3 receptors
ABSTRACT Recently, employing radioligand displacement and functional coupling studies, we demonstrated that SB269,652 (N‐[(1r,4r… Expand
  • figure 1
  • table 1
  • table 2
  • figure 3
  • table 3
Is this relevant?
Review
2018
Review
2018
Dopamine D2 Receptors Dimers: How can we Pharmacologically Target Them?
Background Dopamine D2 and D3 receptors can form homo- and heterodimers and are important targets in Schizophrenia and Parkinson… Expand
Is this relevant?
2017
2017
Synthesis and Pharmacological Characterization of Novel trans-Cyclopropylmethyl-Linked Bivalent Ligands That Exhibit Selectivity and Allosteric Pharmacology at the Dopamine D3 Receptor (D3R).
The development of bitopic ligands directed toward D2-like receptors has proven to be of particular interest to improve the… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Review
2015
Review
2015
Novel dimensions of D3 receptor function: Focus on heterodimerisation, transactivation and allosteric modulation
The brain׳s complexity derives not only from the way the intricate network of neurons is wired, but also by protein complexes… Expand
Is this relevant?
2010
2010
The Tetrahydroisoquinoline Derivative SB 269 , 652 Is an Allosteric Antagonist at Dopamine D 3 and D 2 Receptors
In view of the therapeutic importance of dopamine D3 and D2 receptors, there remains considerable interest in novel ligands… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
2010
2010
The Tetrahydroisoquinoline Derivative SB269,652 Is an Allosteric Antagonist at Dopamine D3 and D2 Receptors
In view of the therapeutic importance of dopamine D3 and D2 receptors, there remains considerable interest in novel ligands… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2003
Highly Cited
2003
The role of dopamine D3 compared with D2 receptors in the control of locomotor activity: a combined behavioural and neurochemical analysis with novel, selective antagonists in rats
BackgroundThe role of dopamine D3/D2 receptors in the control of locomotion is poorly understood.ObjectivesTo examine the… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE